OGEN
Price:
$0.8516
Market Cap:
$3.55M
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials rela...[Read more]
Industry
Biotechnology
IPO Date
2004-02-25
Stock Exchange
AMEX
Ticker
OGEN
According to Oragenics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.71. This represents a change of -37.42% compared to the average of 1.14 of the last 4 quarters.
The mean historical Current Ratio of Oragenics, Inc. over the last ten years is 9.00. The current 0.71 Current Ratio has changed 692.11% with respect to the historical average. Over the past ten years (40 quarters), OGEN's Current Ratio was at its highest in in the March 2021 quarter at 42.27. The Current Ratio was at its lowest in in the June 2025 quarter at 0.71.
Average
9.00
Median
8.48
Minimum
0.87
Maximum
19.17
Discovering the peaks and valleys of Oragenics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 154.76%
Maximum Annual Current Ratio = 19.17
Minimum Annual Increase = -75.98%
Minimum Annual Current Ratio = 0.87
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 0.87 | -59.34% |
| 2023 | 2.15 | -75.98% |
| 2022 | 8.95 | -53.31% |
| 2021 | 19.17 | 43.09% |
| 2020 | 13.40 | 31.61% |
| 2019 | 10.18 | -45.81% |
| 2018 | 18.79 | 134.65% |
| 2017 | 8.01 | 154.76% |
| 2016 | 3.14 | -41.62% |
| 2015 | 5.38 | -61.12% |
The current Current Ratio of Oragenics, Inc. (OGEN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.99
5-year avg
8.91
10-year avg
9.00
Oragenics, Inc.’s Current Ratio is greater than AIM ImmunoTech Inc. (0.64), less than KALA BIO, Inc. (0.75), less than Ensysce Biosciences, Inc. (1.27), less than Soligenix, Inc. (1.47), less than Qualigen Therapeutics, Inc. (8.83), less than Can-Fite BioPharma Ltd. (3.60), less than Xenetic Biosciences, Inc. (4.56), less than CNS Pharmaceuticals, Inc. (5.81), greater than Kazia Therapeutics Limited (0.21), less than Titan Pharmaceuticals, Inc. (11.60),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.64 | $4.19M | |
| 0.75 | $6.77M | |
| 1.27 | $3.86M | |
| 1.47 | $16.43M | |
| 8.83 | $5.43M | |
| 3.60 | $3.65M | |
| 4.56 | $3.92M | |
| 5.81 | $3.74M | |
| 0.21 | $21.67M | |
| 11.60 | $4.44M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oragenics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oragenics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Oragenics, Inc.'s Current Ratio?
How is the Current Ratio calculated for Oragenics, Inc. (OGEN)?
What is the highest Current Ratio for Oragenics, Inc. (OGEN)?
What is the 3-year average Current Ratio for Oragenics, Inc. (OGEN)?
What is the 5-year average Current Ratio for Oragenics, Inc. (OGEN)?
How does the current Current Ratio for Oragenics, Inc. (OGEN) compare to its historical average?